CA2632190A1 - Lung cancer diagnostic assay - Google Patents

Lung cancer diagnostic assay Download PDF

Info

Publication number
CA2632190A1
CA2632190A1 CA002632190A CA2632190A CA2632190A1 CA 2632190 A1 CA2632190 A1 CA 2632190A1 CA 002632190 A CA002632190 A CA 002632190A CA 2632190 A CA2632190 A CA 2632190A CA 2632190 A1 CA2632190 A1 CA 2632190A1
Authority
CA
Canada
Prior art keywords
markers
lung cancer
patient
sample
phage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002632190A
Other languages
English (en)
French (fr)
Inventor
Edward A. Hirschowitz
Li Zhong
Nada H. Khattar
Arnold J. Stromberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2632190A1 publication Critical patent/CA2632190A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002632190A 2005-11-10 2006-11-10 Lung cancer diagnostic assay Abandoned CA2632190A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US73555505P 2005-11-10 2005-11-10
US73541805P 2005-11-10 2005-11-10
US60/735,555 2005-11-10
US60/735,418 2005-11-10
US80677806P 2006-07-08 2006-07-08
US60/806,778 2006-07-08
PCT/US2006/060796 WO2007079284A2 (en) 2005-11-10 2006-11-10 Lung cancer diagnostic assay

Publications (1)

Publication Number Publication Date
CA2632190A1 true CA2632190A1 (en) 2007-07-12

Family

ID=38228904

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002632190A Abandoned CA2632190A1 (en) 2005-11-10 2006-11-10 Lung cancer diagnostic assay

Country Status (9)

Country Link
US (3) US20090197285A1 (https=)
EP (1) EP1952157A4 (https=)
JP (1) JP2009516178A (https=)
KR (1) KR20080073740A (https=)
CN (1) CN103245784A (https=)
AU (1) AU2006332597A1 (https=)
BR (1) BRPI0619712A2 (https=)
CA (1) CA2632190A1 (https=)
WO (1) WO2007079284A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007249805B2 (en) * 2006-05-12 2013-01-10 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
KR101018665B1 (ko) 2008-08-18 2011-03-04 재단법인서울대학교산학협력재단 전립선암 진단 방법 및 장치
WO2012006632A2 (en) * 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
SG187045A1 (en) 2010-08-13 2013-02-28 Somalogic Inc Pancreatic cancer biomarkers and uses thereof
JP5981350B2 (ja) * 2010-12-28 2016-08-31 ライオン株式会社 口腔状態の判定方法、並びにそのために用いられる分析用具、装置、及びプログラム
WO2013074793A1 (en) 2011-11-15 2013-05-23 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
WO2016013400A1 (ja) * 2014-07-24 2016-01-28 国立大学法人 長崎大学 肺癌診断用バイオマーカー
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
US11813926B2 (en) 2020-08-20 2023-11-14 Denso International America, Inc. Binding agent and olfaction sensor
US11828210B2 (en) 2020-08-20 2023-11-28 Denso International America, Inc. Diagnostic systems and methods of vehicles using olfaction
US12251991B2 (en) 2020-08-20 2025-03-18 Denso International America, Inc. Humidity control for olfaction sensors
US11760169B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Particulate control systems and methods for olfaction sensors
US12017506B2 (en) 2020-08-20 2024-06-25 Denso International America, Inc. Passenger cabin air control systems and methods
US11760170B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Olfaction sensor preservation systems and methods
US11881093B2 (en) 2020-08-20 2024-01-23 Denso International America, Inc. Systems and methods for identifying smoking in vehicles
US12377711B2 (en) 2020-08-20 2025-08-05 Denso International America, Inc. Vehicle feature control systems and methods based on smoking
US11932080B2 (en) 2020-08-20 2024-03-19 Denso International America, Inc. Diagnostic and recirculation control systems and methods
US11636870B2 (en) 2020-08-20 2023-04-25 Denso International America, Inc. Smoking cessation systems and methods
US12269315B2 (en) 2020-08-20 2025-04-08 Denso International America, Inc. Systems and methods for measuring and managing odor brought into rental vehicles
CN116312739A (zh) * 2021-12-20 2023-06-23 博尔诚(北京)科技有限公司 基于甲基化测序的标志物筛选方法、癌症检测方法及装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351824A (en) * 1981-02-05 1982-09-28 Icl Scientific Polystyrene latex reagents, methods of preparation, and use in immunological procedures
AU632469B2 (en) * 1988-04-04 1993-01-07 Johns Hopkins University, The A method for early detection of lung cancer
EP0991945B2 (en) * 1997-06-26 2008-02-20 The Regents Of The University Of Michigan Method for identification of tumor antigens with autoantibodies in serum
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
WO2001053349A2 (en) * 2000-01-21 2001-07-26 Ludwig Institute For Cancer Research Small cell lung cancer associated antigens and uses therefor
JP2001343389A (ja) * 2000-03-30 2001-12-14 Nippon Kayaku Co Ltd Mdm2に対する自己抗体の測定によるがんの検査方法およびその試薬
AU2002365228A1 (en) * 2001-11-09 2003-09-02 Brad Nelson Antigen panels and methods of using the same

Also Published As

Publication number Publication date
JP2009516178A (ja) 2009-04-16
WO2007079284A3 (en) 2008-09-18
US20140066329A1 (en) 2014-03-06
EP1952157A4 (en) 2009-04-08
EP1952157A2 (en) 2008-08-06
AU2006332597A1 (en) 2007-07-12
KR20080073740A (ko) 2008-08-11
WO2007079284A2 (en) 2007-07-12
BRPI0619712A2 (pt) 2011-10-11
US20120231966A1 (en) 2012-09-13
US20090197285A1 (en) 2009-08-06
CN103245784A (zh) 2013-08-14

Similar Documents

Publication Publication Date Title
US20120231966A1 (en) Lung cancer diagnostic assay
US20100093108A1 (en) Lung cancer diagnotic assay
US11525832B2 (en) Protein signature/markers for the detection of adenocarcinoma
JP6026422B2 (ja) 肺がん試験
EP2074422A2 (en) Methods and kits for detecting prostate cancer biomarkers
CN112345755A (zh) 乳腺癌的生物标志物及其应用
US8216789B2 (en) Diagnostic panel of cancer antibodies and methods for use
US20140371098A1 (en) Marker sequences for breast cancer and the use thereof
KR20120098992A (ko) 암의 검출을 위한 방법 및 시스템
AU2010252907B2 (en) Methods for the diagnosis or prognosis of colorectal cancer
JP2016519767A (ja) 前立腺がんに対するバイオマーカー検出における使用のための方法とアレイ
CN115877006B (zh) 卵巢癌相关的生物标志物及其应用
US20180106810A1 (en) Detectors of serum biomarkers for predicting ovarian cancer recurrence
US20130196876A1 (en) Differential diagnosis of pancreatic adenomas
CN116413430A (zh) 一种用于肝癌早期预测的自身抗体/抗原组合及检测试剂盒
CN101374962A (zh) 肺癌的诊断分析法
KR20230068378A (ko) 폐암에서 자가항체를 검출하기 위한 항원 조합의 용도
US20140179557A1 (en) Marker sequences for diagnosing prostate cancer, and use thereof
MX2008006130A (en) Lung cancer diagnostic assay
EP2963124B1 (en) Biomarker combinations for use in pancreatic cancer screening
CN113933509A (zh) 抗体测定
GB2600701A (en) Antibody assay

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20180403